hedge funds cormorant asset management llc hedge funds public info on a private industry funds books contact cormorant asset management llc read about hedge funds key facts headquartersboston ma employees aum billion aum as ofmay   clients overview cormorant asset management llc is a hedge fund based in boston ma it was founded in  they hold  billion in assets under management as of may   read their plain english brochure sub funds and performance nameaum bn type min investment num clients internal   fund of funds   prime brokers cormorant global healthcare master fund lp  hedge fund     goldman merrill morgan stanley cormorant private healthcare fund i lp  private equity fund    goldman key people nametitlepositionownership bihua chenmanaging member  chief executive officer owner or officer  nebojsa obradovicchief compliance officer owner or officernone edward scollinsmember chief financial officer  chief operating officer owner or officernone copyright   track hedge funds login cormorant global healthcare fund lp private company information  bloomberg july    am et capital markets company overview of cormorant global healthcare fund lp snapshot people company overview cormorant global healthcare fund lp is a hedge fund launched and managed by cormorant asset management llc the fund invests in the public equity markets it primarily invests in stocks of companies operating in the healthcare sector the fund employs longshort strategy to make its investments cormorant global healthcare fund lp was formed on may   and is domiciled in united states  clarendon streetnd floorboston ma united states phone  fax  key executives for cormorant global healthcare fund lp ms bihua chen portfolio manager compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact cormorant global healthcare fund lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft ﻿ why cormorant global healthcare master fund just disclosed huge new sorrento therapeutics inc stake – octafinance friday  july  menu featured news  years ago  alphabet inc nasdaqgoogl tests its ad technology on billboards to cushion itself against ad blocks  years ago  china margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisis  years ago  marc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and gold  years ago  carl icahn criticizes the fed feels bad for investors buying junk bonds  years ago  john burbank european qe can’t save the markets same as the us quantitative easing everything will be liquidated why cormorant global healthcare master fund just disclosed huge new sorrento therapeutics inc stake  by octastaff in sec g  d filings share with your friendsyour nameyour emailrecipient emailenter a messagei read this article and found it very interesting thought it might be interesting for you the article is called why cormorant global healthcare master fund just disclosed huge new sorrento therapeutics inc stake and is was published by octafinancecom at httpwwwoctafinancecomwhycormorantglobalhealthcaremasterfundjustdisclosedhugenewsorrentotherapeuticsincstakecaptchasubmitcormorant global healthcare master fund new position in sorrento therapeutics inc nasdaqsrne cormorant global healthcare master fund has filled a sc g form regarding sorrento therapeutics inc    filing link sorrento therapeutics inc hedge funds ownership latest sec filings show  hedge funds and institutional investors own sorrento therapeutics inc the institutional ownership of the company in q  is high at  of the shares outstanding they increased by  the total shares they hold as of that quarter these institutional investors owned  shares a total of  funds opened new positions in sorrento therapeutics inc and  increased their holdings there were  funds that closed their positions and  that reduced them  investors have the firm in their top  some of these are venbio select advisor llc cormorant asset management llc belmont global advisors inc is the most positive institutional investor on sorrento therapeutics inc with ownership of  shares as of q  for  of the fund’s portfolio venbio select advisor llc is another positive player owning  shares of the company or  of their stocks portfolio ma cormorant asset management llc have  of their stock portfolio invested in the stock for  further aisling capital llc disclosed it had purchased a stake worth  of the fund’s stock portfolio in the company the nj healthcare value capital llc was also a notable investor in the firm owning  shares sorrento therapeutics inc is  of the fund’s stock portfolio company profile sorrento therapeutics inc is a biopharmaceutical company engaged in the discovery acquisition development and commercialization of drug therapeutics the company’s primary therapeutic focus is oncology including the treatment of chronic cancer pain but is also developing therapeutic products for other indications including immunology and infectious diseases its pipeline consists of lead oncology product cynviloq a micellar paclitaxel formulation resiniferatoxin a nonopiate ultra potent and selective agonist of the transient receptor potential vanilloid receptor for intractable pain in endstage disease as well as fully human therapeutic antibodies derived from its gmab library platform and antibody drug conjugates and recombinant intravenous immunoglobulin the company’s wholly owned subsidiaries include igdrasol inc sherrington pharmaceuticals inc concortis biosystems and sorrento therapeutics inc hong kong limited form g is used when the filer owns between  and  of the company and plans to hold it only as a passive investor if the filler intend to exert control and if the stake’s size exceeds  then a d must be filed therefore activist investors and practices such as hostile takeovers company breakups and other “change of control” events are not permitted by g filers cormorant global healthcare master fund receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with marketbeatcoms free daily email newsletter agtc advisors fund lp just bought bg medicine inc stake polaris venture partners iv lp just decreased acceleron pharma inc’s stake free email newsletter enter your email address below to get the latest news and analysts ratings for your stocks with our free daily email newsletter hedge fund newstop  citadel advisors f holdings in q df dent  co inc just released its q  stock positionsmaverick capital top  holdings in q analyzing ken griffins citadel advisors stock holdings in q lone pine capital top  f positions in q guru newsfelix zulauf sees a stock market correction coming this rally sp  indexspinx will be shortlivedmarc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and goldjim grant the next thing might be helicopter money what to buy and where he sees investment opportunitieskyle bass bearish on emerging markets for at least  more years looking to short currenciesdavid tepper gets defensive is it time to get out of the stock market macro newschina margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisisare us – russian relations a zerosum gameus and russia have launched direct talks on the conflict in syriayuan drops as pboc cuts reference rate by most since devaluationcould the market crash like —put volume spike argues low is nearctas newsred rock just published report about the trend following landscape  how ctas’ performance must be analyzedhow to implement dual momentum for nonus investorsdo commodity trading advisors ctas really provide crisis alpha equity hedge and are long volatility cormorant global healthcare master fund lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active cormorant global healthcare master fund lp • boston ma how do i update this listing cormorant global healthcare master fund is based out of boston whalewisdom has at least  dg filings in our database for cormorant global healthcare master fund summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from cormorant global healthcare master fund lp enter your email address below and choose submit your email cancel contact info cormorant global healthcare master fund lp  clarendon street boston ma     business phone  recent sec filings sc ga filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  current dg holdings stock sector shares held market value rank source source date ardelyx inc ardx health care    g  omeros corp omer health care    g  quotient limited qtnt health care    g  sorrento therapeutics inc srne information technology    g  proteostasis therapeutics inc pti health care    g  recro pharma inc reph health care    g  vitae pharmaceut vtae health care    g  intec pharma ltd ntec health care    g  zynerba pharmaceuticals inc zyne health care    g  aptose bioscienc apto health care    g  genvec inc gnvc health care    g  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free cormorant asset management llc notifies  shareholding in tigenixhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets open in  hrs  minssp futures dow futures nasdaq futures cormorant asset management llc notifies  shareholding in tigenixglobenewswire•july  reblogsharetweetshareregulated informationpress releasecormorant asset management llc notifies  shareholding in tigenixleuven belgium  july   h cest  tigenix nv euronext brussels tig publishes today the transparency notification pursuant to article  of the belgian law of may   regarding the publication of major holdings in issuers whose securities are admitted to trading on a regulated market and including various provisionssummary of the notificationon july   tigenix nv received a transparency notification from cormorant asset management llc following the acquisition of shares on march   by two entities controlled by it ie cormorant global healthcare master fund lp and crma spv lp after which cormorant asset management llc has the discretionary power to exercise  voting rights in tigenix nv  of the voting rights as a result the  threshold was crossedcontent of the notification by cormorant asset management llcdate of the notification july  reason of the notification acquisition of sharesperson subject to the notification requirement cormorant asset management llc who is a person that notifies alonedate on which the threshold was crossed march  threshold that was crossed denominator details of the notification following the acquisition of shares the number of voting rights was as follows cormorant asset management llc holds  voting rights in tigenix nv  of voting rights chain of controlled undertakings through which the holdings are effectively held cormorant asset management llc is not a controlled entity cormorant asset management llc has received the discretionary power to exercise the voting rights of  tigenix shares from the following two entities which are both controlled by it cormorant global healthcare master fund lp and crma spv lpthis press release and the abovementioned transparency notifications can be consulted on our website press release httpwwwtigenixcomenpages notifications httpwwwtigenixcomenpageshareholders for more informationtigenix nvclaudia daugustachief financial officert      claudiadaugustatigenixcomabout tigenixtigenix nv euronext brussels tig is an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic or donorderived expanded stem cells two products from the adiposederived stem cell technology platform are currently in clinical development cx is in phase iii for the treatment of complex perianal fistulas in crohns disease patients cx has completed a phase i sepsis challenge trial and a phase iii trial in rheumatoid arthritis effective july   tigenix acquired coretherapix whose lead cellular product allocsc is currently in a phase ii clinical trial in acute myocardial infarction ami in addition the second product candidate from the cardiac stem cellbased platform acquired from coretherapix allocsc is being developed in a chronic cardiac indication on july   we entered into a licensing agreement with takeda a large pharmaceutical company active in gastroenterology under which takeda acquired the exclusive right to commercialize cx for complex perianal fistulas outside the united states tigenix is headquartered in leuven belgium and has operations in madrid spain for more information please visit wwwtigenixcomthis announcement is distributed by nasdaq omx corporate solutions on behalf of nasdaq omx corporate solutions clientsthe issuer of this announcement warrants that they are solely responsible for the content accuracy and originality of the information contained thereinsource tigenix via globenewswirehugreblogsharetweetsharerecently viewedyour list is emptywhat to read nextsean hannity responds to claim he ran up a  tab at trumps hotel after flying in a yearold lobster from mainebusiness insiderthis will be in everyones household by banyan hillsponsoredmattis was on vacation when trump tweeted transgender ban and he was reportedly appalled by itbusiness insidertrump’s unwitting legacy could be universal health coverageyahoo financevirgin atlantic founder sir richard branson sells pc stake in airline for £m as part of new tieup with air franceklmthe telegraphzuckerberg wifes ambitious secret finally exposedunewzmesponsoredtwitter is only famous now because of president trump nyse traderyahoo finance videogdp — what you need to know in markets on fridayyahoo financerepublicans kill the border taxyahoo financeengineer finds pattern makes millions in stocksmoney morningsponsoredamazon wobble creates ripples across worldwide stock marketsreutersa pga tour pro explained what separates jordan spieth from fellow stars like rory mcilroy and dustin johnsonbusiness insiderverizon q revenue flat as wireless unit sales decline  despite subcriber reboundvarietywomen need to carry this device with themsiren songsponsoredamazon could be the first trillion dollar company nyse traderyahoo finance videorollsroyce motor ceo we’re not in the auto business we’re in the luxury businessyahoo financetrump is acting suspicious because he ‘may be’ innocent fox news saysben i always hire a slew of lawyers when i havent done anything so it makes perfect sense 😂😂join the conversation   cormorant asset management llc notifies  shareholding in tigenix  euronext skip to content skip to navigation indices  index types  footer companies listed on euronext are indexed according to size segments sectors and per national market it is not necessary to apply for inclusion in an index just as a company cannot block its inclusion about euronext about us investisseurs actualité contact us  languages en fr nl pt recherche recherche cours recherche site euronext levée de capitaux accéder aux marchés de capitaux financement par action réaliser une émission obligataire autres opérations de financement procédures d’admissions obligations de déclaration formulaires d’application including application forms listing fees international listings fastpath smes family business tech services pour les émetteurs listing sponsors evénements corporate actions assistance clientèle questions fréquentes issuer directory introductions en bourse euronext euronext growth™ euronext access™ next step trading  produits equities fixed income funds etfs warrants  certificates indices equity derivatives including stock options stock futures dividend derivatives equity index derivatives etf options fx derivatives commodities euronext synapse euronext block mtf euronext expert market atomx euronext collateral services etf onestop shop trading services market status calendrier  horaires fees  charges market quality membership connectivity service  support données de marché products by type including corporate actions historical data index data master files realtime reference data products by asset type including bonds derivatives etps equities derivatives documentation market data news web services euronext app technologie optiq market solutions for exchanges including exchange data publisher universal trading platform ressources calendars  hours rules  regulations mifid ii reports  statistics including statistics index reports exchange delivery settlement price edsp commodities delivery reports it documentation equity derivatives newsletter commodities newsletter events euronext publications including notices infoflashes corporate actions listed company publications including company press releases annual reports financial calendars cormorant asset management llc notifies  shareholding in tigenix view all press releases libellé société tigenix marché euronext isin be symbole tig release  jul   cet cormorant asset management llc notifies  shareholding in tigenix regulated informationpress release cormorant asset management llc notifies  shareholding in tigenix leuven belgium  july   h cest  tigenix nv euronext brussels tig publishes today the transparency notification pursuant to article  of the belgian law of may   regarding the publication of major holdings in issuers whose securities are admitted to trading on a regulated market and including various provisions summary of the notification on july   tigenix nv received a transparency notification from cormorant asset management llc following the acquisition of shares on march   by two entities controlled by it ie cormorant global healthcare master fund lp and crma spv lp after which cormorant asset management llc has the discretionary power to exercise  voting rights in tigenix nv  of the voting rights as a result the  threshold was crossed content of the notification by cormorant asset management llc date of the notification july   reason of the notification acquisition of shares person subject to the notification requirement cormorant asset management llc who is a person that notifies alone date on which the threshold was crossed march   threshold that was crossed  denominator  details of the notification following the acquisition of shares the number of voting rights was as follows cormorant asset management llc holds  voting rights in tigenix nv  of voting rights chain of controlled undertakings through which the holdings are effectively held cormorant asset management llc is not a controlled entity cormorant asset management llc has received the discretionary power to exercise the voting rights of  tigenix shares from the following two entities which are both controlled by it cormorant global healthcare master fund lp and crma spv lp this press release and the abovementioned transparency notifications can be consulted on our website press release httpwwwtigenixcomenpages notifications httpwwwtigenixcomenpageshareholders for more information tigenix nvclaudia daugustachief financial officert      claudiadaugustatigenixcom about tigenix tigenix nv euronext brussels tig is an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic or donorderived expanded stem cells two products from the adiposederived stem cell technology platform are currently in clinical development cx is in phase iii for the treatment of complex perianal fistulas in crohns disease patients cx has completed a phase i sepsis challenge trial and a phase iii trial in rheumatoid arthritis effective july   tigenix acquired coretherapix whose lead cellular product allocsc is currently in a phase ii clinical trial in acute myocardial infarction ami in addition the second product candidate from the cardiac stem cellbased platform acquired from coretherapix allocsc is being developed in a chronic cardiac indication on july   we entered into a licensing agreement with takeda a large pharmaceutical company active in gastroenterology under which takeda acquired the exclusive right to commercialize cx for complex perianal fistulas outside the united states tigenix is headquartered in leuven belgium and has operations in madrid spain for more information please visit wwwtigenixcom hug source tigenix fournisseur thomson reuters one enternext enternextbiz belgium france introductions portugal a propos d’enternext enternext ipos investors aexnl beursbe boursebe bolsadelisboacompt boursedeparisfr my euronext solutions market data realtime data historical data corporate actions index data technology euronext corporate services resources ressources itdocumentation statistiques réglementation cash notices derivatives notices more euronextasia rohstoffe disclaimer footer   euronext conditions dutilisation privacy policy